Volume 5, Number 6—December 1999
Research
Supplementing Tuberculosis Surveillance with Automated Data from Health Maintenance Organizations
Table 1
Code type | Code | Description of code | |
---|---|---|---|
Antituberculosis drugs | |||
Pharmacy dispensing | Isoniazid | ||
Pharmacy dispensing | Ethambutol | ||
Pharmacy dispensing | Rifampin | ||
Pharmacy dispensing | Pyrazinamide | ||
Pharmacy dispensing | Streptomycin | ||
Pharmacy dispensing | Para-aminosalicyclic acid (PAS) | ||
Pharmacy dispensing | Kanamycin | ||
Pharmacy dispensing | Capreomycin | ||
Pharmacy dispensing | Cycloserine | ||
Pharmacy dispensing | Ethionamide | ||
Microbiology codes | |||
CPTa | 87015 | Concentration (any type) for parasites, ova, or tubercle bacillus (TB, AFB) | |
CPT | 87116 | Culture, tubercle, or other acid-fast bacilli; any source, isolation only | |
CPT | 87117 | Culture, tubercle, or other acid-fast bacilli; concentration plus isolation | |
CPT | 87118 | Culture, mycobacteria, definite identification of each organism | |
CPT | 87190 | Sensitivity studies, antibiotic; tubercle bacillus (TB, AFB), each drug | |
CPT | 87206 | Smear, primary source, with interpretation; fluorescent or acid-fast stain for | |
bacteria, fungi, or cell types | |||
ICD-9b procedure | 90.4 | Microscopy examination of sputum | |
ICD-9 procedure | 90.41 | Bacterial smear | |
ICD-9 procedure | 90.42 | Culture | |
ICD-9 procedure | 90.43 | Culture and sensitivity | |
ICD-9 procedure | 90.49 | Other microscopic examination | |
COSTARc | TB234 | AFB smear | |
COSTAR | TB850 | AFB culture and sensitivity | |
Radiology code | |||
CPT | 71010 | Chest, single view, frontal | |
CPT | 71020 | Chest, two views, frontal and lateral | |
CPT | 71021 | Chest with apical lordotic procedure | |
CPT | 71030 | Chest, complete, minimum of four views | |
CPT | 71250 | CT, thorax, without contrast | |
CPT | 71260 | CT, thorax, with contrast | |
CPT | 71270 | CT, thorax, without contrast, followed by contrast | |
CPT | 71550 | MRId chest | |
CPT | 71555 | MRI chest (excluding myocardium) | |
ICD-9 procedure | 87.44 | Chest X-ray | |
COSTAR | TR027 | Chest, PAe only | |
COSTAR | TR028 | Chest X-ray | |
COSTAR | TR029 | Chest, PA, and last with fluoroscopy | |
COSTAR | TR032 | Chest, fluoroscopy | |
COSTAR | TR178 | MRI-chest | |
COSTAR | TR184 | CATf scan-chest | |
COSTAR | TR236 | Chest, PA, and lateral | |
COSTAR | TR237 | Chest-PA, lateral, both obliques | |
COSTAR | TR238 | Chest-four views | |
COSTAR | TR240 | Chest-special views | |
PPDg status | |||
COSTAR | DG249 | Positive PPD | |
COSTAR | DA129 | Tuberculin conversion | |
Diagnosis codes for TB | |||
COSTAR | DR185 | TB | |
COSTAR | DG250 | Pulmonary TB | |
COSTAR | DG251 | Active TB | |
ICD-9 diagnosis | 010.0 | Primary TB infection | |
010.1 | |||
010.8 | |||
ICD-9 diagnosis | 011.0 | Pulmonary TB | |
011.1 | |||
011.2 | |||
011.3 | |||
011.5 | |||
011.6 | |||
011.8 | |||
011.9, | |||
011.90-011.96 | |||
ICD-9 diagnosis | 012.0 | Other respiratory TB | |
012.1 | |||
012.2 | |||
ICD-9 diagnosis | 013.0 | TB of meninges and central nervous system | |
013.1 | |||
013.2 | |||
013.3 | |||
013.4 | |||
013.5 | |||
ICD-9 diagnosis | 015.0 | TB of bones and joints | |
015.7 | |||
015.8 | |||
015.9 | |||
ICD-9 diagnosis | 016.0 | TB of genitourinary system | |
016.3 | |||
ICD-9 diagnosis | 017.2 | TB of peripheral lymph nodes | |
ICD-9 diagnosis | 018.0 | Miliary TB | |
018.8 | |||
018.9 | |||
ICD-9 diagnosis | 795.3 | Sputum positive only | |
Bronchoscopy and biopsy | |||
ICD-9 procedure | 33.22-33.24 | Diagnostic procedures on lung and bronchus | |
33.26-33.28 | Biopsy of lymphatic structure | ||
40.11 |
aCPT, current procedures terminology.
bICD9, International Classification of Diseases, 9th revision.
cCOSTAR, coding system used for the automated ambulatory-patient medical records (10).
dMRI, magnetic resonance imaging.
ePA, posteroanterior.
fCAT, computer-assisted tomography.
gPPD, purified protein derivative of tuberculin.
References
- Platt R. Studies of prescription drugs at Harvard Community Health Plan. In: Strom B, editor. Pharmacoepidemiology. 2d ed. New York: John Wiley and Sons; 1994. p. 278-87.
- Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46(RR-10):40–1.
- Subramanyan G, Yokoe D, Sharnprapai S, Tang Y, Platt R. An algorithm to match registries with minimal disclosure of individual identities. Public Health Rep. 1999;114:91–3. DOIPubMedGoogle Scholar
- Stata statistics and data analysis [computer program]. Version 5.0. College Station (TX): Stata Corporation; 1997.
- Marier R. The reporting of communicable diseases. Am J Epidemiol. 1977;105:587–90.PubMedGoogle Scholar
- McCray E, Weinbaum CM, Braden CR, Onorato IM. The epidemiology of tuberculosis in the United States. Clin Chest Med. 1997;18:99–113. DOIPubMedGoogle Scholar
- Driver C, Braden CR, Nieves R, Navarro AM, Rullan JV, Valway SE, Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992. Public Health Rep. 1996;111:157–61.PubMedGoogle Scholar
- Maggini M, Salmaso S, Alegiani SS, Caffari B, Raschetti R. Epidemiological use of drug prescriptions as markers of disease frequency: An Italian experience. J Clin Epidemiol. 1991;44:1299–307. DOIPubMedGoogle Scholar
- Hripcsak G, Knirsch C, Jain N, Pablos-Mendez A. Automated tuberculosis detection. J Am Med Inform Assoc. 1997;4:376–81.PubMedGoogle Scholar
- Winickoff RN, Barnett GO, Morgan M, Coltin KL. Quality assurance in a prepaid group practice. J Ambul Care Manage. 1979;2:19–28.PubMedGoogle Scholar
Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.